GSE179235 MEK NRAS inhibition 0 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE179235_MEK_NRAS inhibition_0_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE179235_MEK_NRAS inhibition_0_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE179235_MEK_NRAS inhibition_0_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE179235_MEK_NRAS inhibition_0_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 16

Gene

double homeobox A pseudogene 8

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

MIR34A host gene

Gene

DUS4L-BCAP29 readthrough

Gene

endogenous Bornavirus like nucleoprotein 3, pseudogene

Gene

uncharacterized LOC645485

Gene

MIR3142 host gene

Gene

long intergenic non-protein coding RNA 973

Gene

NR2F1 regulatory antisense RNA 1

  • Gene

    small nucleolar RNA host gene 16


  • Gene

    double homeobox A pseudogene 8


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene



  • Gene

    DUS4L-BCAP29 readthrough


  • Gene

    endogenous Bornavirus like nucleoprotein 3, pseudogene


  • Gene

    uncharacterized LOC645485



  • Gene

    long intergenic non-protein coding RNA 973


  • Gene

    NR2F1 regulatory antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.